Advertisement

Bayer Confirms $66 Billion Acquisition Of Monsanto04:56
Download

Play
Bayer, best known in the U.S. for its aspirin, announced the deal to acquire Monsanto on Wednesday. (Roberto Pfeil, John Thys/AFP/Getty Images)
Bayer, best known in the U.S. for its aspirin, announced the deal to acquire Monsanto on Wednesday. (Roberto Pfeil, John Thys/AFP/Getty Images)
This article is more than 4 years old.

Agrochemical giant Monsanto is set to be acquired by Bayer — the largest acquisition so far this year.

The German chemical and pharmaceutical company, best known in the U.S. for its aspirin, announced the deal Wednesday, raising its initial offer for a third time to $66 billion, including debt.

Here & Now's Jeremy Hobson speaks with Nathan Bomey of USA Today about the implications of the deal and how analysts are reacting.

Guest

Nathan Bomey, business reporter for USA Today. He tweets @NathanBomey.

This segment aired on September 14, 2016.

Related:

Advertisement

Advertisement